The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalvern Intl Regulatory News (MLVN)

Share Price Information for Malvern Intl (MLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 18.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 3.00 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 19.50
MLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Loan Facility

8 Jan 2021 07:00

RNS Number : 9923K
Malvern International PLC
08 January 2021
 

 8 January 2021

 

 

MALVERN INTERNATIONAL PLC

("Malvern" or the "Company")

 

New Short-term Loan Facility

Director Loan Note

Trading and Covid Update and New Accreditation

Malvern International plc (AIM: MLVN), the global learning and skills development partner, announces that it has entered into a new short term loan agreement for £350,000 (the "New Loan" or "Loan") with Boost & Co. Ltd ("Boost" or the "Lender"), and that it has secured a further £30,000 via a unsecured loan note with a Director.

The purpose of this new borrowing is to provide bridging finance to ensure the Company has sufficient working capital pending the payment of a significant trade debtor amounting to in excess of £900,000 which is expected to be paid in quarter one 2021.

New Short-term Loan Facility

The New Loan for £350,000 will be drawn in full immediately. Interest on the amounts drawn down will be charged at 11.25% per annum.

In the event that the New Loan is not repaid in full on 30 April 2021, the Lender is entitled to 18,500,000 warrants over 18,500,000 ordinary shares at an exercise price of 0.15 pence per share.

An arrangement fee of 1.5% is payable on the New Loan on the signing of the loan agreement.

The amounts drawn down are secured alongside the existing lending from Boost by way of debentures constituting the first fixed and floating charges over the Group's assets in the UK, including fixed charge security over the shares held in each English subsidiary of the Company.

Director Loan Note

As a condition of the New Loan, Richard Mace, Chief Executive of the Company, has agreed to lend the Company £30,000 by way of an unsecured loan. The loan is repayable on or before 30 April 2021 and attracts interest at 5.0% per annum.

 

Trading and Covid Update

 

In line with the government guidance all schools will be closed from 5th January to 14th February.

 

University Pathway student numbers for the September intake ended up in line with budget with 121 students. It had been hoped that the intake would be ahead of expectations but there was a slight attrition as some of the students decided not to travel due to COVID restrictions, and changing rules with international travel. However, the numbers represent significant growth from previous year's intake and are in line with university expectations. The January 2021 intake is going ahead, starting on 11th January and will be delivered using blended learning, with all teaching being online initially. We are awaiting the advice from the university about the ongoing use of blended learning for the rest of the academic year.

 

Language student bookings had been rebuilding in H2 of 2020. Following the latest government COVID restrictions, we are contacting existing language students who are already in the UK to support them in a smooth transition to online study via Malvern Online Academy.

 

Middle East embassy students that haven not arrived in UK already have permission from embassies to start their studies online and will travel to the UK when they feel safe to do so. The indication from our overseas sales agencies is that students who have not already commenced courses will arrive later, delaying their start until late Spring.

 

NCUK  

In December Malvern was successful with its application to become a NCUK accredited delivery centre from their London Kings Cross centre. NCUK is a consortium of leading universities dedicated to giving international students guaranteed access to universities worldwide.

 

From September 2021 Malvern will accept international and EU students on their nine month NCUK International foundation programme. The programme is designed to prepare international students for undergraduate study at a UK university. On completion of the course, students have guaranteed progression options to over 20 leading partner universities in the UK, as well as established universities in USA, Canada, Australia and New Zealand.

 

The NCUK partnership will add to additional revenue streams that are likely to grow in 2022 and beyond as student numbers increase. The programmes will help attract a wider diversity of students from key recruitment markets. As part of the group strategy, we see this academic foundation programmes as an area of growth.

 

Management recruitment

A few experienced senior managers have been recruited and will join the business in Q1 to support product development and implement growth plans. 

 

Outlook

Overall demand for our education products remains largely unaffected. Further growth in the University Pathway division is predicted for September 2021 and we are currently expecting the Summer programmes to go ahead for language centres and Malvern Juniors.

 

We therefore remain positive about the long-term outlook for the Company, and we are expecting business to resume to normal levels once the vaccine rollout has been administered to key groups. 

 

Commenting on the loan, Mark Elliott, Chairman at Malvern, said:

 

"We have been working closely with Boost and are pleased to have been able to quickly and easily agree this additional short-term support with them.

 

I would like at this time to also express the Board's gratitude to all in Malvern who are managing the challenges exceptionally well during this prolonged period of uncertainty. We continue to build a strong team and a business that we believe will not only survive, but thrive once a greater degree of normality returns."

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For further information please contact:

 

Malvern International Plc

www.malverninternational.com

Mark Elliott - Chairman

Via Communications Portfolio

Richard Mace - Chief Executive Officer

 

WH Ireland (NOMAD & Broker)

www.whirelandcb.com

Mike Coe / Chris Savidge

0207 220 1666

Media enquiries

Communications Portfolio

ariane.comstive@communications-portfolio.co.uk

Ariane Comstive

+44 7785 922 354

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODDDLFBFFLLBBQ
Date   Source Headline
23rd Apr 20247:00 amRNSAnnual Report & Notice of AGM
10th Apr 20247:00 amRNSFinal Results
4th Mar 202412:00 pmRNSIssue of Warrants
14th Feb 202411:02 amRNSCorrection: Trading Update
15th Jan 20245:22 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSContract extension
15th Nov 20237:00 amRNSAppointment of CDO & Grant of EMI Options
3rd Oct 20237:00 amRNSClosure of Malvern House, Brighton
29th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSTrading Update
30th May 202312:37 pmRNSResult of AGM
30th May 20237:00 amRNSTrading Update
15th May 20237:00 amRNSPartnership Agreement
26th Apr 20237:00 amRNSAnnual Report & Notice of Annual General Meeting
12th Apr 20234:23 pmRNSDirector Dealing
12th Apr 20237:00 amRNSDirector Dealing
6th Apr 20237:00 amRNSFinal Results
3rd Apr 202310:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSTrading Update
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20234:40 pmRNSSecond Price Monitoring Extn
19th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Nov 20224:11 pmRNSGrant of Options
10th Nov 20221:48 pmRNSDirectors Dealing
10th Nov 202210:36 amRNSHolding(s) in Company
10th Nov 202210:31 amRNSDirectors Dealing
10th Nov 20227:00 amRNSPlacing and Total Voting Rights
2nd Nov 20223:31 pmRNSCorrection: Result of General Meeting and TVR
2nd Nov 202211:44 amRNSResult of General Meeting and Total Voting Rights
2nd Nov 20227:00 amRNSTrading Update
17th Oct 20227:00 amRNSShare Reorganisation an Notice of General Meeting
17th Oct 20227:00 amRNSShare Reorganisation and Notice of General Meeting
4th Oct 20224:24 pmRNSHolding(s) in Company
29th Sep 20228:23 amRNSHolding(s) in Company
27th Sep 20228:25 amRNSDirector dealings
22nd Sep 20228:42 amRNSDirector dealings
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSHalf-year Report
25th Aug 20227:00 amRNSTrading update
9th Aug 20225:11 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSLoan Conversion and Issue of Equity
8th Jun 202211:33 amRNSResult of AGM & Director Disclosure
23rd May 20227:00 amRNSContract award
4th May 20227:00 amRNSFinal Results
4th Mar 20227:00 amRNSDebt restructuring
4th Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.